Skip to main content
All lobbying filings

HOOPER, LUNDY & BOOKMAN, P.C.

Lobbying for GOVERNMENT COUNSEL, LLC (OBO) PRIME THERAPEUTICS · ​Public Policy and Government Advisory Firm

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · Florida · House · Senate · $10,000.00 income · posted Apr 20, 2026

Official filing document

 Bills named in this filing 2
  • HR 8143
    Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.
  • S 2355
    Patients Deserve Price Tags Act
 Lobbying activity 2
Medicare/Medicaid

H.R. 8143 Ensuring Access to Lower Cost Medicines for Seniors Act of 2026; Public Law 119-75 - The Consolidated Appropriations Act, provisions regulating pharmacy benefit manager practices.

Health Issues

S. 2355 Patients Deserve Price Tags Act provisions related to drug price transparency and patient transparency tools; Department of Labors Notice of Proposed Rulemaking, Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure (RIN 1210-AB37).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem